{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:03:31Z","timestamp":1777014211837,"version":"3.51.4"},"reference-count":58,"publisher":"Informa UK Limited","issue":"9","funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company Diabetes Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Giles Brooke, PhD CMPP, of Elevate Scientific Solutions"},{"DOI":"10.13039\/100001003","name":"Nippon Boehringer Ingelheim Co. Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1080\/14740338.2020.1782884","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T09:34:52Z","timestamp":1592386492000},"page":"1193-1202","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials"],"prefix":"10.1080","volume":"19","author":[{"given":"Hirotaka","family":"Watada","sequence":"first","affiliation":[{"name":"Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Metabolic Disease, Graduate School of Medicine, Tokyo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Medicine Division, Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Biostatistics & Data Science, Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Yarush","sequence":"additional","affiliation":[{"name":"Global Pharmacovigilance, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Heilmann","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Boehringer Ingelheim International GmbH, Ingelheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsutaka","family":"Yasui","sequence":"additional","affiliation":[{"name":"Medicine Division, Nippon Boehringer Ingelheim Co. Ltd, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"cit0001","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2019"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0066"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12810"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-018-0345-3"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2016.1257608"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00376"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18269"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.13772"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-019-00412-x"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00267.2015"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114561992"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-16-1148"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1586\/17446651.2015.1004311"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12451"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1215427"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2364"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2365"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12814"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1347"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13496"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13352"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0724-y"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2017.01.005"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-011-0094-1"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.570745"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14067"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30315-2"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12933"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.170"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S33934"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01123.x"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0573-0"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12910"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1602116"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.06.008"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.09.001"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0385-5"},{"key":"cit0041","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (empagliflozin) prescribing information; 2020 Jan. [cited 2020 Mar 27]. Available from: https:\/\/docs.boehringer-ingelheim.com\/Prescribing%20Information\/PIs\/Jardiance\/jardiance.pdf."},{"key":"cit0042","unstructured":"Boehringer Ingelheim International GmbH. Jardiance (empagliflozin) summary of product characteristics; 2020 Jan 10. [cited 2020 Mar 27]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/jardiance-epar-product-information_en.pdf."},{"key":"cit0043","unstructured":"Nippon Boehringer Ingelheim. Jardiance (empagliflozin) Japanese package insert. [cited 2020 Mar 27]. Available from: https:\/\/www.info.pmda.go.jp\/go\/pack\/3969023F1023_1_10\/."},{"key":"cit0044","unstructured":"Boehringer Ingelheim Pharmaceuticals, Inc. GLYXAMBI (empagliflozin and linagliptin) prescribing information; 2020 Jan. [cited 2020 Mar 27]. Available from: https:\/\/docs.boehringer-ingelheim.com\/Prescribing%20Information\/PIs\/Glyxambi\/Glyxambi.pdf."},{"key":"cit0045","unstructured":"Boehringer Ingelheim International GmbH. Glyxambi (empagliflozin and linagliptin) summary of product characteristics; 2019 Dec 10. [cited 2020 Mar 27]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/glyxambi-epar-product-information_en.pdf."},{"key":"cit0046","unstructured":"Nippon Boehringer Ingelheim. Tradians (empagliflozin and linagliptin) Japanese package insert. [cited 2020 Mar 27]. Available from: https:\/\/www.info.pmda.go.jp\/go\/pack\/3969108F1027_1_02\/."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13564"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30182-1"},{"issue":"11","key":"cit0050","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1681\/ASN.2018010103","volume":"29","author":"Wanner C","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"issue":"1","key":"cit0052","first-page":"S28S35","volume":"124","author":"Thomson SC","year":"2019","journal-title":"Am J Cardiol"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4839-8"},{"key":"cit0055","unstructured":"Janssen Pharmaceuticals, Inc. INVOKANA (canagliflozin) prescribing information; 2020 Jan. [cited 2020 Mar 27]. Available from: http:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/INVOKANA-pi.pdf."},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1551"},{"key":"cit0057","unstructured":"Merck Serono Limited. Glucophage (metformin) summary of product characteristics; 2019 August. [cited 2020 Mar 27]. Available from https:\/\/hcp.merckgroup.com\/content\/dam\/web\/healthcare\/diabetes\/glucophage-ir\/MRP%20SPC%20LAB%20PL%20Glucophage%20500mg%20fct%20Type%20IAIN%20122%202017Jan10%20en%20app.pdf."},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1096"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2020.1782884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:05:26Z","timestamp":1620450326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2020.1782884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1080\/14740338.2020.1782884"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2020.1782884","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}